Stage-specific embryonic antigen: determining expression in canine glioblastoma, melanoma, and mammary cancer cells

J Vet Sci. 2017 Mar 30;18(1):101-104. doi: 10.4142/jvs.2017.18.1.101.

Abstract

The expression of stage-specific embryonic antigens (SSEAs) was determined in several types of canine cancer cells. Flow cytometry showed SSEA-1 expression in glioblastoma, melanoma, and mammary cancer cells, although none expressed SSEA-3 or SSEA-4. Expression of SSEA-1 was not detected in lymphoma, osteosarcoma, or hemangiosarcoma cell lines. Relatively stable SSEA-1 expression was observed between 24 and 72 h of culture. After 8 days in culture, sorted SSEA-1- and SSEA-1+ cells re-established SSEA-1 expression to levels comparable to those observed in unsorted cells. Our results document, for the first time, the expression of SSEA-1 in several canine cancer cell lines.

Keywords: canine cancer; flow cytometry; magnetic-activated cell sorting; stage-specific embryonic antigens.

MeSH terms

  • Animals
  • Cell Differentiation
  • Cell Line, Tumor
  • Dog Diseases
  • Dogs
  • Female
  • Flow Cytometry / veterinary
  • Glioblastoma / etiology
  • Glioblastoma / metabolism
  • Glioblastoma / veterinary*
  • Mammary Neoplasms, Animal / etiology
  • Mammary Neoplasms, Animal / metabolism*
  • Melanoma / etiology
  • Melanoma / metabolism
  • Melanoma / veterinary*
  • Stage-Specific Embryonic Antigens / metabolism*

Substances

  • Stage-Specific Embryonic Antigens